405 related articles for article (PubMed ID: 28671018)
21. Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.
Yu T; Yang G; Hou Y; Tang X; Wu C; Wu XA; Guo L; Zhu Q; Luo H; Du YE; Wen S; Xu L; Yin J; Tu G; Liu M
Oncogene; 2017 Apr; 36(15):2131-2145. PubMed ID: 27721408
[TBL] [Abstract][Full Text] [Related]
22. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
23. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.
Barton M; Filardo EJ; Lolait SJ; Thomas P; Maggiolini M; Prossnitz ER
J Steroid Biochem Mol Biol; 2018 Feb; 176():4-15. PubMed ID: 28347854
[TBL] [Abstract][Full Text] [Related]
24. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen Resistance: Emerging Molecular Targets.
Rondón-Lagos M; Villegas VE; Rangel N; Sánchez MC; Zaphiropoulos PG
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548161
[TBL] [Abstract][Full Text] [Related]
26. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
27. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.
Revankar CM; Bologa CG; Pepermans RA; Sharma G; Petrie WK; Alcon SN; Field AS; Ramesh C; Parker MA; Savchuk NP; Sklar LA; Hathaway HJ; Arterburn JB; Oprea TI; Prossnitz ER
Cell Chem Biol; 2019 Dec; 26(12):1692-1702.e5. PubMed ID: 31706983
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer.
Abbas MA; Al-Kabariti AY; Sutton C
J Steroid Biochem Mol Biol; 2024 Jul; 241():106523. PubMed ID: 38636681
[TBL] [Abstract][Full Text] [Related]
29. Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.
Chimento A; Casaburi I; Rosano C; Avena P; De Luca A; Campana C; Martire E; Santolla MF; Maggiolini M; Pezzi V; Sirianni R
Mol Nutr Food Res; 2014 Mar; 58(3):478-89. PubMed ID: 24019118
[TBL] [Abstract][Full Text] [Related]
30. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
31. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
[TBL] [Abstract][Full Text] [Related]
32. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
33. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
34. Insight into the mechanism of tetrachlorobisphenol A (TCBPA)-induced proliferation of breast cancer cells by GPER-mediated signaling pathways.
Lei B; Tang Q; Sun S; Zhang X; Huang Y; Xu L
Environ Pollut; 2021 Apr; 275():116636. PubMed ID: 33582643
[TBL] [Abstract][Full Text] [Related]
35. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
Girgert R; Emons G; Gründker C
Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
[TBL] [Abstract][Full Text] [Related]
36. Perfluoroalkyl substances promote breast cancer progression via ERα and GPER mediated PI3K/Akt and MAPK/Erk signaling pathways.
Liu Q; Liu Y; Li X; Wang D; Zhang A; Pang J; He J; Chen X; Tang NJ
Ecotoxicol Environ Saf; 2023 Jun; 258():114980. PubMed ID: 37148752
[TBL] [Abstract][Full Text] [Related]
37. The G protein-coupled estrogen receptor as a modulator of neoplastic transformation.
Jacenik D; Cygankiewicz AI; Krajewska WM
Mol Cell Endocrinol; 2016 Jul; 429():10-8. PubMed ID: 27107933
[TBL] [Abstract][Full Text] [Related]
38. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
[TBL] [Abstract][Full Text] [Related]
39. [GPER receptor - the new player in estrogen signaling].
Cygankiewicz AI; Jacenik D; Krajewska WM
Postepy Biochem; 2015; 61(1):52-60. PubMed ID: 26281354
[TBL] [Abstract][Full Text] [Related]
40. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
Tao S; He H; Chen Q; Yue W
Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]